Reuters -- Consumer goods group Reckitt Benckiser expects good growth in its core business this year to compensate for an expected loss of earnings from its Suboxone drug, after fourth quarter profits rose as expected.
Reuters -- Consumer goods group Reckitt Benckiser expects good growth in its core business this year to compensate for an expected loss of earnings from its Suboxone drug, after fourth quarter profits rose as expected.
